ICU Medical Inc（ICUI）股票分析ICUIICU Medical Inc

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

ICU Medical Inc is a good buy right now due to its current price of $166.62, a strong RSI of 62.15 indicating bullish momentum, and a forward P/E of 16.95 suggesting reasonable valuation compared to growth prospects. Additionally, the company has shown a significant gross margin improvement to 42.61% in Q2 2026, reflecting operational efficiency and profitability. The main risk to consider is the recent insider selling, where the CFO sold shares worth $1.1 million, which could raise concerns among investors, but this was part of a pre-scheduled trading plan and not indicative of negative company performance.

5 analysts cover ICUI: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 173.50.